Редактирование: Aging genes 20-29 (раздел)

==EPO==

* {{medline-title
|title=Myokines as biomarkers of frailty and cardiovascular disease risk in females.
|date=05.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32017952
|full-text-url=https://sci-hub.do/10.1016/j.exger.2020.110859
}}
* {{medline-title
|title=Regulation of muscle and metabolic physiology by hypothalamic erythropoietin independently of its peripheral action.
|date=02.2020
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/32029230
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938905
}}
* {{medline-title
|title=Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease.
|date=2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31550724
|full-text-url=https://sci-hub.do/10.1159/000502525
}}
* {{medline-title
|title=Age-Dependent Systemic Effects of a Systemic Intermittent Hypoxic Therapy [i]In Vivo[/i].
|date=09.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/31260338
|full-text-url=https://sci-hub.do/10.1089/ham.2018.0113
}}
* {{medline-title
|title=Erythropoietin does not improve fracture healing in aged mice.
|date=15.07.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30998964
|full-text-url=https://sci-hub.do/10.1016/j.exger.2019.04.005
}}
* {{medline-title
|title=Dose-response relationship of intermittent normobaric hypoxia to stimulate erythropoietin in the context of health promotion in young and old people.
|date=05.2019
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/30756167
|full-text-url=https://sci-hub.do/10.1007/s00421-019-04096-8
}}
* {{medline-title
|title=rh[[EPO]] Enhances Cellular Anti-oxidant Capacity to Protect Long-Term Cultured Aging Primary Nerve Cells.
|date=08.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28634693
|full-text-url=https://sci-hub.do/10.1007/s12031-017-0937-6
}}
* {{medline-title
|title=[Effects of recombinant human erythropoietin on brain-derived neurotrophic factor expression in different brain regions of aging rats].
|date=20.04.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28446413
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744085
}}
* {{medline-title
|title=Warming Up to New Possibilities with the Capsaicin Receptor [[TRPV1]]: mTOR, AMPK, and Erythropoietin.
|date=2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28294062
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478459
}}
* {{medline-title
|title=The Anti-Aging Effect of Erythropoietin via the ERK/Nrf2-ARE Pathway in Aging Rats.
|date=03.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/28168414
|full-text-url=https://sci-hub.do/10.1007/s12031-017-0885-1
}}
* {{medline-title
|title=Age-associated expression of erythropoietin and its receptor in rat spiral ganglion neurons and its association with neuronal apoptosis and hearing alterations.
|date=01.2017
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27959434
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355685
}}
* {{medline-title
|title=Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy.
|date=2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27488211
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079807
}}
* {{medline-title
|title=Erythropoietin Does Not Enhance Skeletal Muscle Protein Synthesis Following Exercise in Young and Older Adults.
|date=2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27458387
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937030
}}
* {{medline-title
|title=Oxidative stress induces the decline of brain [[EPO]] expression in aging rats.
|date=10.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27452792
|full-text-url=https://sci-hub.do/10.1016/j.exger.2016.07.012
}}
* {{medline-title
|title=Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
|date=14.06.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/27248662
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094944
}}
* {{medline-title
|title=Erythropoietin Attenuates the Memory Deficits in Aging Rats by Rescuing the Oxidative Stress and Inflammation and Promoting [[BDNF]] Releasing.
|date=10.2016
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26482461
|full-text-url=https://sci-hub.do/10.1007/s12035-015-9438-1
}}
* {{medline-title
|title=rh[[EPO]] affects apoptosis in hippocampus of aging rats by upregulating [[SIRT1]].
|date=2015
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/26261574
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525908
}}
* {{medline-title
|title=Coated dextrin microcapsules of amlodipine incorporable into orally disintegrating tablets for geriatric patients.
|date=10.2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/25458788
|full-text-url=https://sci-hub.do/10.1016/j.biopha.2014.10.010
}}
* {{medline-title
|title=Neocytolysis: none, one or many? A reappraisal and future perspectives.
|date=2014
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24592241
|full-text-url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924315
}}
* {{medline-title
|title=[Effect of erythropoietin on activities of antioxidant enzymes in the brain tissue of aged rats].
|date=09.2013
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24067215

}}
* {{medline-title
|title=[The anti-aging effect of [[EPO]] and the preliminary probe into its mechanisms].
|date=09.2012
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/23230737

}}